Back to search
Secondary Hemophagocytic Lymphohistiocytosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hemophagocytic Lymphohistiocytosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Hemophagocytic Lymphohistiocytosis trials you may qualify forHemophagocytic lymphohistiocytosis is a rare, aggressive and life-threatening syndrome of excessive immune activation. Secondary hemophagocytic lymphohistiocyto…
Background: Hemophagocytic lymphohistiocytosis (HLH) is a disease caused by disrupted immune function. People with HLH are prone to fevers and illnesses, which…
For patients who met the inclusion criteria, treatment regimens were administered: Rituximab 375 mg/m², intravenously, once weekly for 4 weeks. Zanubrutinib 16…
The goal of this observational study is to learn if interferon-gamma monoclonal antibody combined with dexamethasone works to treat adults with refractory secon…
The purpose of this study is to assess the safety, tolerability and efficacy of emapalumab in children and adults with macrophage activation syndrome (sHLH/MAS)…
The study to evaluate the effect of cyclosporine ( IL2 inhibitor and antiviral) verse standard care treatment on decrease ADRS, hyper inflammation, hypercytokin…